Form 8-K · Current report
Elevance Health 8-K, filed Sep 10, 2026
- Filed
- CIK
- 0001156039
- Accession no.
- 0001156039-26-000063
Summary
Officers of Elevance Health expect to speak with investors and analysts over the next several weeks and will reaffirm full-year 2026 shareholders' earnings guidance of at least $20.10 per diluted share, including approximately $6.90 per diluted share of net unfavorable items, and adjusted shareholders' earnings of at least $27.00 per diluted share. They will also reaffirm full-year 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.
Key points
- Elevance Health officers plan investor and analyst meetings over the next several weeks.
- Full-year 2026 shareholders' earnings guidance is expected to be at least $20.10 per diluted share, including approximately $6.90 per diluted share of net unfavorable items.
- Adjusted shareholders' earnings guidance for full year 2026 is expected to be at least $27.00 per diluted share, excluding those net unfavorable items and not including other adjustment items beyond those reported in second quarter 2026.
- Full-year 2026 benefit expense ratio guidance is expected to be 90.2% plus or minus 50 basis points.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
From the filing
Item 7.01 - Regulation FD Disclosure Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors and analysts over the next several weeks. During these meetings, Company officers will reaffirm the Company’s shareholders’ earnings guidance for full year 2026 to be at least $20.10 per diluted share, including approximately $6.90 per diluted share of net unfavorable items. Excluding these items, the Company continues to expect adjusted shareholders’ earnings to be at least $27.00 per diluted share. This does not include any other adjustment items beyond those reported in the Company's second quarter 2026 earnings. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.